Page last updated: 2024-09-02

fingolimod hydrochloride and Scleroderma, Localized

fingolimod hydrochloride has been researched along with Scleroderma, Localized in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimoto, M; Hamaguchi, Y; Hasegawa, M; Huu, DL; Jin, G; Matsushita, T; Takehara, K1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Scleroderma, Localized

ArticleYear
FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
    Arthritis and rheumatism, 2013, Volume: 65, Issue:6

    Topics: Animals; Bone Marrow Transplantation; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Fingolimod Hydrochloride; Flow Cytometry; Graft vs Host Disease; Immunohistochemistry; Immunosuppressive Agents; Male; Mice; Propylene Glycols; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Scleroderma, Localized; Skin; Sphingosine; Spleen

2013